Skip to content
healthcare.dev

Mesalamine

NDC 0093-5907, Mesalamine, capsule, delayed release, from Teva Pharmaceuticals USA, Inc..

Product NDC
0093-5907
Status
Listed
Labeler
Teva Pharmaceuticals USA, Inc.
Dosage form
CAPSULE, DELAYED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA207873
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5907 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE400 mg/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
0093-5907-8600093590786180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0093-5907-86)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6fd0a906-e1b5-4238-a79b-a195510ddc84
  • NADAC price for package 00093590786

    GET /v1/drugs/nadac/00093590786

Use it

Look up 0093-5907 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0093-5907 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0093-5907. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.